is tirzepatide a dual agonist Tirzepatide, GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Tirzepatide 10mg — Dual Receptor

They are not for human consumption, therapeutic use, diagnostic use or medical application

10.1097/CCM.0000000000002814 113 WichmannA.AllahyarA.GreinerT

To view or add a comment, sign in Struggling with GLP-1 therapy side effects

Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rnne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nhr J, Lu TT, Polex-Wolf J, Prevot V, Raun K, Simonsen L, Sun G, Szilvsy-Szab A, Willenbrock H, Secher A, Knudsen LB, Hogendorf WFJ

You develop drugs to target specific diseases one by one

Significant improvements in eating behavior scores were observed after 6 months of semaglutide treatment [60]